Cargando…
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
BACKGROUND: Immunotherapies targeting CTLA-4 and PD-1 have elicited promising responses in a variety of cancers. However, the relatively low response rates warrant the identification of additional immunosuppressive pathways. V domain immunoglobulin suppressor of T cell activation (VISTA) plays a cri...
Autores principales: | Xie, Xiaoxue, Zhang, Junying, Shi, Zhongyuan, Liu, Wanmei, Hu, Xinlei, Qie, Chenxin, Chen, Wenting, Wang, Yan, Wang, Li, Jiang, Jingwei, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673447/ https://www.ncbi.nlm.nih.gov/pubmed/33250890 http://dx.doi.org/10.3389/fimmu.2020.563044 |
Ejemplares similares
-
M351‐0056 is a novel low MW compound modulating the actions of the immune‐checkpoint protein VISTA
por: Hu, Xinlei, et al.
Publicado: (2021) -
Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir(-/-) murine psoriasis
por: Qie, Chenxin, et al.
Publicado: (2020) -
Structural Basis of VSIG3: The Ligand for VISTA
por: Xie, Xiaoxue, et al.
Publicado: (2021) -
Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
por: Zheng, Meijun, et al.
Publicado: (2023) -
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)